About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Mindfulness During COVID-19 | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT04319445

Mindfulness During COVID-19

The objective of this study is to provide remote mindfulness session(s) to help during the COVID-19 pandemic.

Lead sponsor: Wake Forest University Health Sciences•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Wake Forest University Health Sciences

The objective of this study is to provide remote mindfulness session(s) to help during the COVID-19 pandemic.The investigators are interested in targeting patients with migraine, providers, faculty and staff. The investigators are hopeful that this will positively impact overall well-being at this stressful time. The investigators are interested in assessing feasibility, accessibility, and overall interest of an online mindfulness intervention in these populations at this time.

Age

All ages

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Any person interested in participating in the mindfulness session will be eligible to complete the pre/post surveys and participate in the mindfulness session.

Exclusion Criteria

•None

Related studies

RECRUITINGPhase 2

Psilocybin-Assisted Cognitive Processing Therapy for Chronic PTSD

NCT06386003 · Post Traumatic Stress Disorder, PTSD, and more

RECRUITINGPhase 2

Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder

NCT05837104 · Bipolar I Disorder, Depression, Anxiety, and more

The New Empowerment After eXposure to Trauma (NEXT) Study

NCT07175025 · PTSD - Post Traumatic Stress Disorder, PTSD (Childbirth-Related)

Predictability of the Clinical Global Impression Scale (CGI) in Post Immediate in Psychotraumatic Impact

NCT05358067 · Post-traumatic Stress Disorder

Augmenting Urinary Reflex Activity Study 4 (Including eXtended Indications)

NCT06885931 · Mixed Urinary Incontinence, Stress Urinary Incontinence (SUI), and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 2, 2022Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment144

Start dateMar 2020

Last updatedMar 2, 2022

Condition

Migraine Disorders Stress Anxiety

Locations shown

Wake Forest Health Sciences

Winston-Salem, North Carolina

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 2, 2022Data synced to Clareo: June 27, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions